- Home
- NERV vs GIFT Comparison
NERV vs GIFT Comparison
Compare NERV & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | GIFT |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 31.0M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | NERV | GIFT |
|---|---|---|
| Price | $4.71 | $1.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | $4.00 |
| AVG Volume (30 Days) | ★ 45.9K | 32.1K |
| Earning Date | 02-24-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $86,142,442.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $0.82 |
| 52 Week High | $12.46 | $2.38 |
Technical Indicators
Market Signals| Indicator | NERV | GIFT |
|---|---|---|
| Relative Strength Index (RSI) | 67.06 | 53.25 |
| Support Level | $3.82 | $1.02 |
| Resistance Level | $4.24 | $1.15 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 89.56 | 64.13 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About GIFT RDE Inc.
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.